Skip to content
Adam Torkildson – Lifestyle
Author:
Vicore Pharma Holding
Increase in Number of Shares and Votes in Vicore Pharma
September 30, 2026
Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum
September 17, 2026
Vicore Pharma to Participate in Upcoming Healthcare Conferences
September 1, 2026
Vicore Pharma to Present at the European Respiratory Society Congress 2026
August 24, 2026
Vicore Pharma to Participate in the Leerink Therapeutics Forum
July 7, 2026
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer
July 6, 2026
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market
July 1, 2026
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape
June 2, 2026
Vicore Pharma to Present at the Jefferies Global Healthcare Conference
May 26, 2026
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC
May 22, 2026
1
2
Next Page
→